a Department of Nephrology , The First Affiliated Hospital of Wenzhou Medical University , Wenzhou , China.
b Department of Nephrology , Zhejiang Chinese Medical University Affiliated Wenzhou Hospital of Traditional Chinese Medicine , Wenzhou , China.
Ren Fail. 2019 Nov;41(1):363-369. doi: 10.1080/0886022X.2019.1605294.
This study aimed to investigate the unique prognostic, clinical, and renal histopathological characteristics of patients with idiopathic membranous nephropathy (IMN) with different levels of proteinuria.
This retrospective observational study included 190 IMN patients with low levels of proteinuria (low group), 193 IMN patients with medium levels of proteinuria (medium group), and 123 IMN patients with high levels of proteinuria (high group) treated between September 2006 and November 2015. Prognostic and baseline clinical and histopathological data were compared among the three groups. Poor prognostic events included the occurrence of a persistent 50% reduction in estimated glomerular filtration rate (eGFR), end-stage renal disease, or all-cause mortality.
The severity of clinical symptoms and laboratory indices, such as blood pressure; extent of edema and hematuria; levels of fibrinogen, immunoglobulin (Ig)-G, complement (C)-4, total protein, albumin (ALB), and serum creatinine (SCr); and eGFR increased with increasing proteinuria (all p< .001). Based on renal histopathology, the extent of segmental sclerosis and balloon adhesion and renal interstitial lesion stage also increased in severity with increasing proteinuria (all p< .001). The Kaplan-Meier analysis showed that compared with patients with low and medium levels of proteinuria, patients with high levels of proteinuria had significantly lower cumulative poor event-free renal survival rates (p= .0039).
Baseline proteinuria level is indicative of prognosis in IMN patients; the greater the extent of proteinuria is, the worse the prognosis.
本研究旨在探讨不同蛋白尿水平的特发性膜性肾病(IMN)患者的独特预后、临床和肾组织病理学特征。
本回顾性观察性研究纳入了 190 例蛋白尿水平较低(低水平组)、193 例蛋白尿水平中等(中水平组)和 123 例蛋白尿水平较高(高水平组)的 IMN 患者,他们均于 2006 年 9 月至 2015 年 11 月接受治疗。比较三组患者的预后和基线临床及组织病理学数据。不良预后事件包括估计肾小球滤过率(eGFR)持续下降 50%、终末期肾病或全因死亡率的发生。
临床症状和实验室指标(如血压、水肿和血尿程度、纤维蛋白原、免疫球蛋白(Ig)-G、补体(C)-4、总蛋白、白蛋白(ALB)和血清肌酐(SCr)水平以及 eGFR)的严重程度随蛋白尿的增加而增加(均 p<0.001)。基于肾组织病理学,节段性硬化和球囊粘连以及肾间质病变的严重程度也随蛋白尿的增加而加重(均 p<0.001)。Kaplan-Meier 分析显示,与蛋白尿水平较低和中等的患者相比,蛋白尿水平较高的患者累积不良无事件肾生存率显著降低(p=0.0039)。
基线蛋白尿水平可预测 IMN 患者的预后;蛋白尿程度越严重,预后越差。